Bristol-Myers Squibb Meets on the Top Line, Misses Where it Counts
Bristol-Myers Squibb (NYS: BMY) reported earnings on Jan. 26. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Bristol-Myers Squibb met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded, and earnings per share grew significantly.
Gross margins increased, operating margins dropped, net margins expanded.
Bristol-Myers Squibb logged revenue of $5.45 billion. The 15 analysts polled by S&P Capital IQ foresaw revenue of $5.53 billion. Sales were 6.7% higher than the prior-year quarter's $5.11 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.
Non-GAAP EPS came in at $0.53. The 19 earnings estimates compiled by S&P Capital IQ predicted $0.55 per share on the same basis. GAAP EPS of $0.50 for Q4 were 78% higher than the prior-year quarter's $0.28 per share.
Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.
For the quarter, gross margin was 74.9%, 200 basis points better than the prior-year quarter. Operating margin was 28.9%, 90 basis points worse than the prior-year quarter. Net margin was 15.6%, 610 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $5.23 billion. On the bottom line, the average EPS estimate is $0.61.
Next year's average estimate for revenue is $18.24 billion. The average EPS estimate is $1.98.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bristol-Myers Squibb is outperform, with an average price target of $32.40.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Bristol-Myers Squibb. Learn how to maximize your investment income with this report: "Secure Your Future With 11 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Bristol-Myers Squibb to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.